Home/Filings/4/0001354488-14-005642
4//SEC Filing

Cellular Biomedicine Group, Inc. 4

Accession 0001354488-14-005642

CIK 0001378624operating

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 10:04 AM ET

Size

4.9 KB

Accession

0001354488-14-005642

Insider Transaction Report

Form 4
Period: 2014-11-10
Transactions
  • Other

    Common Stock

    2014-11-10+2,403188,340 total
Footnotes (1)
  • [F1]Reporting Person received 2,403 shares of common stock, par value $0.001 per share (?Common Stock?), of Cellular Biomedicine Group, Inc. (the ?Company?), which shares (the ?Compensation Shares?) were issued as compensation for the Reporting Person?s first two years of service on the board of Cellular Biomedicine Group Ltd., the Company?s wholly-owned British Virgin Islands subsidiary.

Issuer

Cellular Biomedicine Group, Inc.

CIK 0001378624

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001378624

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 10:04 AM ET
Size
4.9 KB